Just Biotherapeutics
2014
FOUNDED
PRIVATE
STATUS
71-80
EMPLOYEES
Series B
LATEST DEAL TYPE
$35M
LATEST DEAL AMOUNT
11
INVESTORS
Description
Operator of integrated design company focused on technologies that will accelerate development of biotherapeutics and substantially reduce their manufacturing cost. The company's core strengths are molecular design, process and product design and manufacturing plant design. In addition, they offer a suite of biotherapeutic research and development services, leveraging a fully integrated technology platform, delivering lasting value to clients by creating access to important biologics in a global marketplace.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Primary Office
- South Lake Union
- 401 Terry Avenue North
- Seattle, WA 98109
- United States
+1 (206) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Just Biotherapeutics’s full profile, request a free trial.
Just Biotherapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series B) | 06-Jun-2018 | $35M | 00000 | Completed | Generating Revenue | |
| 4. Early Stage VC (Series B) | 08-Aug-2017 | 0000 | 0000 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A2) | 25-Jul-2016 | 0000 | 0000 | 0000 | Completed | Startup |
| 2. Grant | 06-Nov-2015 | $9.4M | $15M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 18-Sep-2015 | $15M | $15M | 000.00 | Completed | Startup |
Just Biotherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 000 |
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Just Biotherapeutics Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Hillhouse Capital Group | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Bank of Hangzhou Company | Corporation | Minority | 000 0000 | 000000 0 | ||
| Heda Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | ||
| ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Just Biotherapeutics Executive Team (16)
1 Former Executive
You’re viewing 5 of 16 executives. Get the full list »Just Biotherapeutics Board Members (10)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Charles Cooney Ph.D | Self | Board Member | 000 0000 | |
| Hingge Hsu MD | Self | Board Member | 000 0000 | |
| James Thomas Ph.D | Just Biotherapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Judith Li | Lilly Asia Ventures | Board Member | 000 0000 | |
| Khoo Shih Ph.D | Temasek Holdings | Board Member | 000 0000 |